Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis.

Warren RB, Weiss A, Felding J, Sommer MOA

Open source

DOI
10.1007/s13555-025-01371-9
Published
2025 Apr
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-025-01371-9,
  title = {Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis.},
  author = {Warren RB and Weiss A and Felding J and Sommer MOA},
  year = {2025},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-025-01371-9},
  url = {https://doi.org/10.1007/s13555-025-01371-9}
}

RIS

TY  - JOUR
TI  - Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis.
AU  - Warren RB
AU  - Weiss A
AU  - Felding J
AU  - Sommer MOA
PY  - 2025
JO  - Dermatology and therapy
DO  - 10.1007/s13555-025-01371-9
UR  - https://doi.org/10.1007/s13555-025-01371-9
ER  - 

APA

RB, W., A, W., J, F., & MOA, S. (2025). Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis.. Dermatology and therapy. https://doi.org/10.1007/s13555-025-01371-9

Source records